Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Invitation to presentation of Magle Chemoswed’s report for Q1 2022

Magle Chemoswed Holding

Today, on 5 May 2022, Magle Chemoswed Holding AB (publ) has published its interim report for Q1 2022.

On Monday 9 May at 11:00 CEST, the company will hold a web conference hosted by CEO Justin Pierce and CFO Petra Jönsson Sjölin. After their presentation, there will be a Q&A session. The conference will be held in English. You can join the conference by computer or mobile device.

The number of participants is limited and we recommend signing up early to secure a spot. Please register at the following link:

https://attendee.gotowebinar.com/register/4349459514924866317

A recording of the web conference will afterwards be available on Magle Chemoswed’s homepage https://maglegroup.com/ and on Västra Hamnen Corporate Finance’s YouTube channel.

Contacts


Megi Medzmariashvili, Legal Counsel, phone +46 (0)76 164 33 12, megi.medzmariashvili@maglechemoswed.com

About Us


The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes two operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products. Learn more on www.maglechemoswed.com and https://maglegroup.com/ and www.maglepharmacept.com

Västra Hamnen Corporate Finance is the Company's certified advisor on Nasdaq First North Growth Market and can be reached at ca@vhcorp.se or +46 (0) 40 200 250.

Attachments


Invitation to presentation of Magle Chemoswed’s report for Q1 2022

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.